TERF1 and neoplasm: This reduction in telomeric length is consistent with previous studies showing overexpression of TRF1 that resulted in a gradual and progressive reduction in telomere length in tumor-cell line HT1080 and such an effect could be nullified using a dominant-negative allele of TRF1 without the telomeric DNA binding myb domain [14].